N4 Pharma PLC Holding(s) in Company (1153H)
March 08 2018 - 4:05AM
UK Regulatory
TIDMN4P
RNS Number : 1153H
N4 Pharma PLC
08 March 2018
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
-----------------------------------------------------------------------------------
1. Identity of the issuer or N4 PHARMA PLC
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
----------------------------------------------------------- ----------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
-----------------------------------------------------------------------------------
An acquisition or disposal of voting rights
------------------------------------------------------------ ---------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------------ ---------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------------ ---------------------
An event changing the breakdown of voting rights X
------------------------------------------------------------ ---------------------
Other (please
specify):
---------------------------------------------------------- ---------------------
3. Full name of person(s) NIGEL JAMES THEOBALD
subject to the
notification obligation:
(iii)
----------------------------------------------------------- ----------------------
4. Full name of shareholder(s)
(if different from 3.):(iv)
----------------------------------------------------------- ----------------------
5. Date of the transaction 8 MARCH 2018
and date on
which the threshold is
crossed or
reached: (v)
----------------------------------------------------------- ----------------------
8 MARCH 2018
----------------------------------------------------------- ----------------------
7. Threshold(s) that is/are
crossed or
reached: (vi, vii) 19%
----------------------------------------------------------- ----------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- -------------------------------- ---------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
------------- --------------- --------------- ------------- --------------------------- -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------- ----------- ----------- ------------- ------------- ------------ ------------ -----------
GB00BYW8QM32 16,846,633 16,846,633 16,846,633 16,846,633 18.91%
--------------- --------------- ------------- ------------- ------------ ------------ -----------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
----------------- ------------- ------------------------------ ----------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
--------------- ------------- ------------- --------------- ----------------------------- -----------------------
Nominal Delta
--------------- ------------- ------------- --------------- ----------------------------- ------------ ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------------------------------- -------------------------------------------------------------------
16,846,633 18.91%
------------------------------------------------- -------------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
----------------------------------------------------------------------------------------------
Proxy Voting:
----------------------------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------- -------------------------------
11. Number of voting rights proxy
holder will cease
to hold:
------------------------------------------------------------- -------------------------------
12. Date on which proxy holder will
cease to hold
voting rights:
------------------------------------------------------------- -------------------------------
13. Additional information: The Company's issued share
capital increased on 8 March
2018 as a result of exercises
of warrants
------------------------------------------------------------- -------------------------------
14. Contact name: Nigel Theobald
------------------------------------------------------------- -------------------------------
15. Contact telephone number: + 44 1332 690061
------------------------------------------------------------- -------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLLLFIIVVITIIT
(END) Dow Jones Newswires
March 08, 2018 05:05 ET (10:05 GMT)
N4 Pharma (LSE:N4P)
Historical Stock Chart
From Apr 2024 to May 2024
N4 Pharma (LSE:N4P)
Historical Stock Chart
From May 2023 to May 2024